Stock comparison
BECTON DICKINSON & CO is 2.1x more valuable than WEST PHARMACEUTICAL SERVICES INC by market capitalization ($49.62 B vs $23.86 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BDX is larger
BECTON DICKINSON & CO is 2.1x more valuable than WEST PHARMACEUTICAL SERVICES INC by market capitalization ($49.62 B vs $23.86 B).
Market value leader
BDX
BECTON DICKINSON & CO is 2.1x more valuable than WEST PHARMACEUTICAL SERVICES INC by market capitalization ($49.62 B vs $23.86 B).
Revenue leader
BDX
WST: $3.07B vs BDX: $21.84B.
Profit leader
BDX
WST: $493.70M vs BDX: $1.68B.
Margin leader
WST
WST: 16.1% vs BDX: 7.7% net margin.
| Metric | WST | BDX |
|---|---|---|
| Market cap | $23.86 B | $49.62 B |
| US-listed rank | #551 | #322 |
| Revenue (latest FY) | $3.07B | $21.84B |
| Net income (latest FY) | $493.70M | $1.68B |
| Net margin | 16.1% | 7.7% |
| P/E (trailing FY) | 48.3x | 29.6x |
| SEC filings | 3,429 | 3,027 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BECTON DICKINSON & CO is 2.1x more valuable than WEST PHARMACEUTICAL SERVICES INC by market capitalization ($49.62 B vs $23.86 B).
In their latest fiscal years, WEST PHARMACEUTICAL SERVICES INC reported $3.07B in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: WEST PHARMACEUTICAL SERVICES INC and BECTON DICKINSON & CO, or browse the full rankings.